四节段裂谷热病毒疫苗可在妊娠母羊中安全应用
裂谷热病毒(RVFV)在非洲大陆和阿拉伯半岛引起严重且反复的暴发。研究将RVFV的M基因组片段拆分为两个M型片段,构建四节段RVFV(RVFV-4s)疫苗候选株。小鼠鼻腔接种后未引起脑炎,妊娠母羊接种后未引起病毒血症、未穿过胎盘屏障,表明该疫苗病毒可安全用于妊娠母羊。
要点
- RVFV-4s是将M基因组片段拆分为两个M型片段构建的四节段疫苗候选株。
- 小鼠鼻腔接种RVFV-4s后未引起脑炎。
- 妊娠母羊接种RVFV-4s后未引起病毒血症,未穿过胎盘屏障。
核心结论
- RVFV-4s疫苗病毒可在妊娠母羊中安全应用。
研究设计与样本
- 研究构建了四节段RVFV(RVFV-4s)变异株,将M基因组片段拆分为两个M型片段,各编码一种结构糖蛋白Gn或Gc。
- 研究进行了小鼠鼻腔接种实验和妊娠母羊接种实验。
主要发现
- 小鼠鼻腔接种RVFV-4s后未引起脑炎。
- 妊娠母羊接种RVFV-4s后未引起病毒血症。
- 妊娠母羊接种RVFV-4s后未穿过羊胎盘屏障,表现为胎儿血液和器官中无病毒、无致畸效应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rift Valley fever virus (RVFV) causes severe and recurrent outbreaks on the African continent and the Arabian Peninsula and continues to expand its habitat. This mosquito-borne virus, belonging to the genus Phlebovirus of the family Bunyaviridae contains a tri-segmented negative-strand RNA genome. Previously, we developed four-segmented RVFV (RVFV-4s) variants by splitting the M-genome segment into two M-type segments each encoding one of the structural glycoproteins; Gn or Gc. Vaccination/challenge experiments with mice and lambs subsequently showed that RVFV-4s induces protective immunity against wild-type virus infection after a single administration. To demonstrate the unprecedented safety of RVFV-4s, we here report that the virus does not cause encephalitis after intranasal inoculation of mice. A study with pregnant ewes subsequently revealed that RVFV-4s does not cause viremia and does not cross the ovine placental barrier, as evidenced by the absence of teratogenic effects and virus in the blood and organs of the fetuses. Altogether, these results show that the RVFV-4s vaccine virus can be applied safely in pregnant ewes.
引用
- Wichgers Schreur PJ, van Keulen L, Kant J, et al. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy. Vaccine. 2017. PMID: 28457675. doi:10.1016/j.vaccine.2017.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。